Comment Venetoclax with rituxumab highly active in relapsed refractory CLL

>> DOWNLOAD LINK 🎞️ #1 <<

>> DOWNLOAD LINK 🎞️ #2 <<

>> DOWNLOAD LINK 🎵 MP3 <<

############################# Video Source: www.youtube.com/watch?v=Pv1-4KzfdjM

Visit http://www.ecancer.org for more • Prof Anton Hagenbeek (University Medical Center Utrecht, Utrecht, Netherlands) talks to ecancertv at EHA 2015 about the results of Dr Andrew Roberts' early phase Ib trial which looked at combining the anti-bcl-2 drug venetoclax with rituximab to eliminate chronic lymphocytic leukaemia (CLL).

#############################